ASX Share rice
Wed 05 Aug 2020 - 12:40:am (Sydney)

NYR Share Price

NYRADA INC.NYRPharmaceuticals, Biotechnology & Life Sciences

NYR Company Information

Name:

Nyrada Inc

Sector:

Healthcare

Industry:

Biotechnology

Address:

828 Pacific Highway Gordon NSW Australia 2072

Phone:

61 2 9053 1990

Chief Exec. Officer:

Mr. James Bonnar

Founder, Pres & Non-Independent Exec. Director:

Dr. Graham Edmund Kelly

Chief Financial Officer:

Mr. Cameron Jones

Chief Scientific Officer:

Mr. Benjamin Evison

Sr. VP of US Operations:

Mr. Mark Waring

Company Overview:

Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular, neurodegenerative, and chronic inflammatory diseases. Its products in drug development stage include PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury; a drug to treat pain associated with peripheral nerve damage; and a drug to treat autoimmune diseases, such as psoriasis. The company was founded in 2017 and is based in Gordon, Australia.

NYR Share Price Information

Shares Issued:

109.38M

Market Capitalisation:

$20.24M

Revenue (TTM):

$486.34K

Revenue Per Share (TTM):

$0.03

Operating Margin (TTM):

$-7.07

Return On Assets (TTM):

$-1

Gross Profit(TTM):

$-554,863

Diluted Earnings Per Share (TTM):

$-0.25

NYR CashFlow Statement

CashFlow Date:

2019-06-30

Change To Liabilities:

$0.90M

Total Cashflow From Investing Activities:

$-441

Net Income:

$-4,095,130

Total Cash From Operating Activities:

$-2,005,359

Depreciation:

$1.41K

Change To Account Receivables:

$20.37K

Capital Expenditures:

$441

NYR Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-4,095,130

Net Income:

$-4,095,130

Gross Profit:

$-554,863

Operating Income:

$-3,463,590

Other Operating Expenses:

$47.22K

Interest Expense:

$-650,899

Total Revenue:

$486.34K

Total Operating Expenses:

$3.95M

Cost Of Revenue:

$1.04M

NYR Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$37K

Total Liabilities:

$6.10M

Total Stockholder Equity:

$-4,954,466

Other Current Liabilities:

$1.97M

Total Assets:

$1.14M

Common Stock:

$37K

Other Current Assets:

$3

Retained Earnings:

$-6,511,406

Cash:

$1.10M

Total Current Liabilities:

$6.10M

Short-Term Debt:

$3.93M

Property - Plant & Equipment:

$3.74K

Net Tangible Assets:

$-4,991,466

Total Current Assets:

$1.10M

Net Receivables:

$3

Accounts Payable:

$152.28K

NYR Share Price History

NYR News